Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bio-Techne Cp (NQ: TECH )

356.59 USD +0.91 (+0.26%)
Official Closing Price Updated: 4:05 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bio-Techne Cp

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Meet the People Behind the Innovation in 2019
Tags Booz Allen Hamilton Innovation tech
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Bio-Techne's Exosome Diagnostics Lab Receives Accreditation From College of American Pathologists (CAP)
Bio-Techne Corporation (NASDAQ:TECH) today announced that the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to its Exosome Diagnostics (ExosomeDx)... 
From PR Newswire
T-Mobile Selects 30 Teams of Visionary Youth From Across the Country As 2019 Changemaker Challenge Winners
Tags women in stem T/Mobile tech
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Benevity Expands Market-Leading CSR Platform to Mobile, Enabling More Inclusive, In-the-Moment Giving
Tags Employee Giving Community Development Philanthropy & Cause Initiatives
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Bio-Techne To Present At The Evercore ISI 2nd Annual HealthCONx Conference
Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December... 
From PR Newswire
Bio-Techne To Present At The 2019 Stifel Healthcare Conference
Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019 at... 
From PR Newswire
Bio-Techne Licenses aTAG Technology from C4 Therapeutics, Inc.
Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, today announced the signing of an... 
From PR Newswire
Bio-Techne To Present At The Stephens Nashville Investment Conference
Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer, will present at the Stephens Nashville Investment Conference on Wednesday, November 13, 2019 at 9:45 a.m.... 
From PR Newswire
Inspiring Women Leaders in IT
Tags Responsible Business & Employee Engagement talent Jobs
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Bio-Techne Declares Dividend
Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2019. The quarterly dividend will be... 
From PR Newswire
Bio-Techne Releases First Quarter Fiscal 2020 Results
Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2019. 
From PR Newswire
Bio-Techne Announces Investment For New GMP Manufacturing Facility
Bio-Techne Corporation (NASDAQ: TECH), a global leader in the development and manufacturing of Good Manufacturing Practices (GMP)-grade raw and ancillary reagents, announced a commitment to invest... 
From PR Newswire
Medicare Issues Final Local Coverage Decision For Bio-Techne's ExoDx™ Prostate(IntelliScore) Test
Bio-Techne Corporation (NASDAQ:TECH) today announced that the Medicare Administrative Contractor (MAC) National Government Services, Inc. issued a final Local Coverage Decision (LCD) covering the ExoDx... 
From PR Newswire
Bio-Techne To Host Conference Call On October 29, 2019, To Announce First Quarter 2020 Financial Results
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, October 29, 2019, at 8:00 a.m. CDT to review first quarter 2020 financial results. 
From PR Newswire
Bio-Techne Leverages The RNAscope™ Technology To Advance A Multiomic Approach To Antibody Validation
Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of... 
From PR Newswire
Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility
Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media manufacturing facility in Flowery Branch,... 
From PR Newswire
Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ System
Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower® Control Kit for the ProteinSimple™-branded Maurice platform. This new kit enables users to collect, manage and... 
From PR Newswire
Bio-Techne To Present At The Baird 2019 Global Healthcare Conference
Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4,... 
From PR Newswire
Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay
Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the... 
From PR Newswire
Bio-Techne Releases Fourth Quarter Fiscal 2019 Results
Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2019. 
From PR Newswire
Bio-Techne Declares Dividend
Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2019. The quarterly dividend will be payable... 
From PR Newswire
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay
Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the... 
From PR Newswire
Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results
Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, August 6, 2019, at 8:00 a.m. CDT to review fourth quarter 2019 financial results. 
From PR Newswire
Bio-Techne Releases 32x8 Cartridge For The Ella Platform
Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8-Plex cartridge format for the ProteinSimple™-branded Ella™ automated immunoassay platform. This new cartridge format analyzes... 
From PR Newswire
Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues
Expanding research tools for Spatial Genomics by combining molecular information with spatial context in one simple assay. 
From PR Newswire
Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland
Bio-Techne Corporation (NASDAQ: TECH) today announced that its President and CEO, Chuck Kummeth, was recently honored with the EY Entrepreneur Of The Year® 2019 Award in the Heartland. The EY awards... 
From PR Newswire
Bio-Techne China Recognized With "Decade of Contribution Award"
Bio-Techne Corporation (NASDAQ: TECH) was recently honored with the "Decade of Contribution Award" at the 2019 (10th) International Conference on Cell Therapy conference. This award recognized the... 
From PR Newswire
Bio-Techne Appoints Rupert Vessey to Board of Directors
Bio-Techne Corporation today announced the appointment of Dr. Rupert Vessey to the company's Board of Directors as an independent director. Dr. Vessey's appointment brings the total number of... 
From PR Newswire
Ylopo Introduces RAIYA, AI Powered by Search Data
Tags Santa Monica Technology Tech
From PRLog
FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test
Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.